Rice Hall James & Associates’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,095
| Closed | -$267K | – | 314 |
|
|
2021
Q4 | $267K | Sell |
2,095
-151
| -7% | -$19.2K | 0.01% | 294 |
|
|
2021
Q3 | $292K | Sell |
2,246
-270
| -11% | -$35.1K | 0.01% | 283 |
|
|
2021
Q2 | $447K | Sell |
2,516
-529
| -17% | -$94K | 0.02% | 264 |
|
|
2021
Q1 | $501K | Sell |
3,045
-550
| -15% | -$90.5K | 0.02% | 259 |
|
|
2020
Q4 | $593K | Sell |
3,595
-53,351
| -94% | -$8.8M | 0.02% | 253 |
|
|
2020
Q3 | $8.12M | Buy |
56,946
+20,993
| +58% | +$2.99M | 0.33% | 66 |
|
|
2020
Q2 | $3.97M | Buy |
35,953
+3,781
| +12% | +$417K | 0.17% | 118 |
|
|
2020
Q1 | $3.21M | Sell |
32,172
-677
| -2% | -$67.5K | 0.18% | 119 |
|
|
2019
Q4 | $4.9M | Sell |
32,849
-2,191
| -6% | -$327K | 0.17% | 120 |
|
|
2019
Q3 | $4.49M | Sell |
35,040
-800
| -2% | -$103K | 0.16% | 120 |
|
|
2019
Q2 | $5.11M | Sell |
35,840
-6,995
| -16% | -$997K | 0.17% | 127 |
|
|
2019
Q1 | $6.12M | Buy |
42,835
+1,301
| +3% | +$186K | 0.2% | 122 |
|
|
2018
Q4 | $5.15M | Buy |
41,534
+6,540
| +19% | +$811K | 0.19% | 125 |
|
|
2018
Q3 | $5.88M | Sell |
34,994
-493
| -1% | -$82.9K | 0.21% | 112 |
|
|
2018
Q2 | $6.11M | Buy |
35,487
+3,485
| +11% | +$600K | 0.22% | 115 |
|
|
2018
Q1 | $4.83M | Buy |
32,002
+535
| +2% | +$80.8K | 0.19% | 108 |
|
|
2017
Q4 | $4.24M | Buy |
31,467
+13,008
| +70% | +$1.75M | 0.17% | 113 |
|
|
2017
Q3 | $2.7M | Buy |
18,459
+3,563
| +24% | +$521K | 0.12% | 146 |
|
|
2017
Q2 | $2.32M | Buy |
+14,896
| New | +$2.32M | 0.1% | 168 |
|